FDA approves Vosevi for Hepatitis C



The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.



Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*